Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...

In October 2025, Karolinska Institutet launched a brand-new two-week course giving PhD students a unique insight into how ...

Two researchers at the University of California, Davis, have been awarded a VinFuture Prize in recognition of their work ...

Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now ...

Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, ...

Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...

Patients with a previously untreatable form of blood cancer are now living disease-free after a world-first gene therapy. Alyssa Tapley, 16, became the first patient with an aggressive form of ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Salt stress is a major factor that impairs plant growth and yield. In a breakthrough, researchers from Waseda University have ...